BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 20195281)

  • 1. Cross-presentation of HCMV chimeric protein enables generation and measurement of polyclonal T cells.
    Nguyen TH; Sullivan LC; Kotsimbos TC; Schwarer AP; Mifsud NA
    Immunol Cell Biol; 2010 Aug; 88(6):676-84. PubMed ID: 20195281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ex vivo stimulation and expansion of both CD4(+) and CD8(+) T cells from peripheral blood mononuclear cells of human cytomegalovirus-seropositive blood donors by using a soluble recombinant chimeric protein, IE1-pp65.
    Vaz-Santiago J; Lulé J; Rohrlich P; Jacquier C; Gibert N; Le Roy E; Betbeder D; Davignon JL; Davrinche C
    J Virol; 2001 Sep; 75(17):7840-7. PubMed ID: 11483727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-ordinated isolation of CD8(+) and CD4(+) T cells recognizing a broad repertoire of cytomegalovirus pp65 and IE1 epitopes for highly specific adoptive immunotherapy.
    Zandvliet ML; van Liempt E; Jedema I; Veltrop-Duits LA; Willemze R; Guchelaar HJ; Falkenburg JH; Meij P
    Cytotherapy; 2010 Nov; 12(7):933-44. PubMed ID: 20078388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of a lentiviral vector encoding a HCMV-chimeric IE1-pp65 protein for epitope identification in HLA-Transgenic mice and for ex vivo stimulation and expansion of CD8(+) cytotoxic T cells from human peripheral blood cells.
    Rohrlich PS; Cardinaud S; Lulè J; Montero-Julian FA; Prodhomme V; Firat H; Davignon JL; Perret E; Monseaux S; Necker A; Michelson S; Lemonnier FA; Charneau P; Davrinche C
    Hum Immunol; 2004 May; 65(5):514-22. PubMed ID: 15172452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Refinement in the production and purification of recombinant HCMV IE1-pp65 protein for the generation of epitope-specific T cell immunity.
    Nguyen TH; Mifsud NA; Stewart LA; Rose MJ; Etto TL; Williamson NA; Purcell AW; Kotsimbos T; Schwarer AP
    Protein Expr Purif; 2008 Sep; 61(1):22-30. PubMed ID: 18539483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human cytomegalovirus proteins pp65 and immediate early protein 1 are common targets for CD8+ T cell responses in children with congenital or postnatal human cytomegalovirus infection.
    Gibson L; Piccinini G; Lilleri D; Revello MG; Wang Z; Markel S; Diamond DJ; Luzuriaga K
    J Immunol; 2004 Feb; 172(4):2256-64. PubMed ID: 14764694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human cytomegalovirus pp65- and immediate early 1 antigen-specific HLA class I-restricted cytotoxic T cell responses induced by cross-presentation of viral antigens.
    Tabi Z; Moutaftsi M; Borysiewicz LK
    J Immunol; 2001 May; 166(9):5695-703. PubMed ID: 11313411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL.
    Wills MR; Carmichael AJ; Mynard K; Jin X; Weekes MP; Plachter B; Sissons JG
    J Virol; 1996 Nov; 70(11):7569-79. PubMed ID: 8892876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IE1-pp65 recombinant protein from human CMV combined with a nanoparticulate carrier, SMBV, as a potential source for the development of anti-human CMV adoptive immunotherapy.
    Vaz-Santiago J; Lulé J; Rohrlich P; Kravtzoff R; Le Roy E; Davignon JL; Betbeder D; Davrinche C
    Cytotherapy; 2002; 4(1):11-9. PubMed ID: 11953037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural bases for the affinity-driven selection of a public TCR against a dominant human cytomegalovirus epitope.
    Gras S; Saulquin X; Reiser JB; Debeaupuis E; Echasserieau K; Kissenpfennig A; Legoux F; Chouquet A; Le Gorrec M; Machillot P; Neveu B; Thielens N; Malissen B; Bonneville M; Housset D
    J Immunol; 2009 Jul; 183(1):430-7. PubMed ID: 19542454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of transgenic HLA A*0201/Kb and HHD II mice to evaluate frequency of cytomegalovirus IE1-derived peptide usage in eliciting human CD8 cytokine response.
    Gallez-Hawkins G; Villacres MC; Li X; Sanborn MC; Lomeli NA; Zaia JA
    J Virol; 2003 Apr; 77(7):4457-62. PubMed ID: 12634406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of cytomegalovirus-specific human T-lymphocyte clones by using autologous B-lymphoblastoid cells with stable expression of pp65 or IE1 proteins: a tool to study the fine specificity of the antiviral response.
    Retière C; Prod'homme V; Imbert-Marcille BM; Bonneville M; Vié H; Hallet MM
    J Virol; 2000 May; 74(9):3948-52. PubMed ID: 10756006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolating cytomegalovirus-specific T cells for adoptive transfer: are we there yet?
    Bollard CM
    Cytotherapy; 2010 Nov; 12(7):857-8. PubMed ID: 20942604
    [No Abstract]   [Full Text] [Related]  

  • 14. Preparation and characterization of HLA-A*0201 tetramer loaded with IE-1316-324 antigenic peptide of human cytomegalovirus.
    Xu L; Zha Q; Sun H; Jia Q; Li F; He X
    Cell Mol Immunol; 2006 Oct; 3(5):367-71. PubMed ID: 17092434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of HLA-A*0201-restricted T cell responses by natural polymorphism in the IE1(315-324) epitope of human cytomegalovirus.
    Prod'homme V; Retière C; Imbert-Marcille BM; Bonneville M; Hallet MM
    J Immunol; 2003 Feb; 170(4):2030-6. PubMed ID: 12574373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity of Specific CD4+ and CD8+ T Cells Stimulated by CMV pp65 and IE1 Antigens.
    Albiero E; Amati E; Baumeister E; Einsele H; Grigoleit GU; Rodeghiero F
    J Immunother; 2016; 39(9):329-342. PubMed ID: 27631893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immunodominant CD8 T cell response to the human cytomegalovirus tegument phosphoprotein pp65(495-503) epitope critically depends on CD4 T cell help in vaccinated HLA-A*0201 transgenic mice.
    Reiser M; Wieland A; Plachter B; Mertens T; Greiner J; Schirmbeck R
    J Immunol; 2011 Sep; 187(5):2172-80. PubMed ID: 21810614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human cytomegalovirus-specific CD4+ and CD8+ T cell responses in primary infection of the immunocompetent and the immunocompromised host.
    Lilleri D; Zelini P; Fornara C; Comolli G; Revello MG; Gerna G
    Clin Immunol; 2009 Jun; 131(3):395-403. PubMed ID: 19268633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of CD8 T cell reactivity to cytomegalovirus using protein-spanning pools of overlapping pentadecapeptides.
    Kern F; Faulhaber N; Frömmel C; Khatamzas E; Prösch S; Schönemann C; Kretzschmar I; Volkmer-Engert R; Volk HD; Reinke P
    Eur J Immunol; 2000 Jun; 30(6):1676-82. PubMed ID: 10898504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of HLA-G-restricted human cytomegalovirus pp65 (UL83)-specific cytotoxic T lymphocytes in HLA-G transgenic mice.
    Lenfant F; Pizzato N; Liang S; Davrinche C; Le Bouteiller P; Horuzsko A
    J Gen Virol; 2003 Feb; 84(Pt 2):307-317. PubMed ID: 12560562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.